FDA approves drug to prevent heart failure in type 2 diabetes patients
Farxiga, a treatment to reduce the risk of heart failure in patients with type 2 diabetes has been approved by the FDA.
List view / Grid view
Farxiga, a treatment to reduce the risk of heart failure in patients with type 2 diabetes has been approved by the FDA.
Researchers have revealed the top 10 drugs by annual revenue in 2025. Here, we investigate the indications that necessitate these treatments and the delivery systems they employ.
The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
It has been announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMA) for oral semaglutide.
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
Lixisenatide has shown prevention of kidney damage in patients with type 2 diabetes or cardiovascular disease through a study by the EASD...
A new observational study has identified no benefit from prescribing statins to healthy pensioners aged over 75 to prevent heart disease...
Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...
Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...
Scientists have developed an online interactive app to help motivate patients to be more active in managing their disease...